Literature DB >> 4781799

Haemoglobin Nottingham, beta FG 5 (98) valgly: a new unstable haemoglobin producing severe haemolysis.

E C Gordon-Smith, J V Dacie, T E Blecher, E A French, B G Wiltshirre, H Lehmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4781799      PMCID： PMC1644991     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  5 in total

1.  HEREDITARY HEINZ-BODY ANAEMIA, THROMBOCYTOPENIA, AND HAEMOGLOBINOPATHY (HB KOELN) IN A GLASGOW FAMILY.

Authors:  H E HUTCHISON; P H PINKERTON; P WATERS; H LEHMANN; D BEALE; A S DOUGLAS
Journal:  Br Med J       Date:  1964-10-31

2.  HEREDITARY HEINZ-BODY ANAEMIA. A REPORT OF STUDIES ON FIVE PATIENTS WITH MILD ANAEMIA.

Authors:  J V DACIE; A J GRIMES; A MEISLER; L STEINGOLD; E H HEMSTED; G H BEAVEN; J C WHITE
Journal:  Br J Haematol       Date:  1964-07       Impact factor: 6.998

3.  Abnormal haem binding and globin SH group blockade in unstable haemoglobins.

Authors:  H S Jacob; M C Brain; J V Dacie; R W Carrell; H Lehmann
Journal:  Nature       Date:  1968-06-29       Impact factor: 49.962

4.  Three-dimensional Fourier synthesis of horse oxyhaemoglobin at 2.8 A resolution: the atomic model.

Authors:  M F Perutz; H Muirhead; J M Cox; L C Goaman
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

5.  Defective synthesis of an unstable haemoglobin: haemoglobin Koln (beta 98 Val-Met).

Authors:  J M White; M C Brain
Journal:  Br J Haematol       Date:  1970-02       Impact factor: 6.998
  5 in total
  2 in total

1.  De novo mutations producing unstable hemoglobins or hemoglobins M : I. Establishment of a Depository and use of data to test for an association of de novo mutation with advanced parental age.

Authors:  G Stamatoyannopoulos; P E Nute; M Miller
Journal:  Hum Genet       Date:  1981-10       Impact factor: 4.132

2.  Hb Nottingham or alpha 2 beta 2 98 (FG5) Val-->Gly in a Czech child.

Authors:  V Brabec; K Indrák; H Fortová; J Suttnar; B Blazek; J Cermák; V Divoký; L Vepreková; J Zeman
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.